Literature DB >> 27177020

The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51.

M Antunica-Noguerol1,2, M L Budziñski1, J Druker1, N C Gassen3, M C Sokn1, S Senin1, F Aprile-Garcia1,2, F Holsboer4, T Rein3, A C Liberman1, E Arzt1,2.   

Abstract

FK506-binding protein 51 (FKBP51) regulates the activity of the glucocorticoid receptor (GR), and is therefore a key mediator of the biological actions of glucocorticoids. However, the understanding of the molecular mechanisms that govern its activity remains limited. Here, we uncover a novel regulatory switch for GR activity by the post-translational modification of FKBP51 with small ubiquitin-like modifier (SUMO). The major SUMO-attachment site, lysine 422, is required for FKBP51-mediated inhibition of GR activity in hippocampal neuronal cells. Importantly, impairment of SUMO conjugation to FKBP51 impacts on GR-dependent neuronal signaling and differentiation. We demonstrate that SUMO conjugation to FKBP51 is enhanced by the E3 ligase PIAS4 and by environmental stresses such as heat shock, which impact on GR-dependent transcription. SUMO conjugation to FKBP51 regulates GR hormone-binding affinity and nuclear translocation by promoting FKBP51 interaction within the GR complex. SUMOylation-deficient FKBP51 fails to interact with Hsp90 and GR thus facilitating the recruitment of the closely related protein, FKBP52, which enhances GR transcriptional activity. Moreover, we show that the modification of FKBP51 with SUMO modulates its binding to Hsp90. Our data establish SUMO conjugation as a novel regulatory mechanism in the Hsp90 cochaperone activity of FKBP51 with a functional impact on GR signaling in a neuronal context.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27177020      PMCID: PMC5041187          DOI: 10.1038/cdd.2016.44

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  59 in total

1.  SUMO-1 conjugation in vivo requires both a consensus modification motif and nuclear targeting.

Authors:  M S Rodriguez; C Dargemont; R T Hay
Journal:  J Biol Chem       Date:  2000-12-21       Impact factor: 5.157

2.  The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo.

Authors:  Daniel L Riggs; Patricia J Roberts; Samantha C Chirillo; Joyce Cheung-Flynn; Viravan Prapapanich; Thomas Ratajczak; Richard Gaber; Didier Picard; David F Smith
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

Review 3.  Concepts in sumoylation: a decade on.

Authors:  Ruth Geiss-Friedlander; Frauke Melchior
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

4.  Interaction of moloney murine leukemia virus capsid with Ubc9 and PIASy mediates SUMO-1 addition required early in infection.

Authors:  Andrew Yueh; Juliana Leung; Subarna Bhattacharyya; Lucy A Perrone; Kenia de los Santos; Szy-Yuan Pu; Stephen P Goff
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding.

Authors:  W B Denny; D L Valentine; P D Reynolds; D F Smith; J G Scammell
Journal:  Endocrinology       Date:  2000-11       Impact factor: 4.736

6.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18

7.  Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors.

Authors:  Mehdi Mollapour; Dimitra Bourboulia; Kristin Beebe; Mark R Woodford; Sigrun Polier; Anthony Hoang; Raju Chelluri; Yu Li; Ailan Guo; Min-Jung Lee; Elham Fotooh-Abadi; Sahar Khan; Thomas Prince; Naoto Miyajima; Soichiro Yoshida; Shinji Tsutsumi; Wanping Xu; Barry Panaretou; William G Stetler-Stevenson; Gennady Bratslavsky; Jane B Trepel; Chrisostomos Prodromou; Len Neckers
Journal:  Mol Cell       Date:  2014-01-23       Impact factor: 17.970

8.  B-Raf and CRHR1 internalization mediate biphasic ERK1/2 activation by CRH in hippocampal HT22 Cells.

Authors:  Juan J Bonfiglio; Carolina Inda; Sergio Senin; Giuseppina Maccarrone; Damián Refojo; Damiana Giacomini; Christoph W Turck; Florian Holsboer; Eduardo Arzt; Susana Silberstein
Journal:  Mol Endocrinol       Date:  2013-01-31

9.  Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells.

Authors:  Ana C Liberman; Jimena Druker; Damian Refojo; Florian Holsboer; Eduardo Arzt
Journal:  FASEB J       Date:  2009-01-05       Impact factor: 5.191

10.  Compound A, a dissociated glucocorticoid receptor modulator, inhibits T-bet (Th1) and induces GATA-3 (Th2) activity in immune cells.

Authors:  Ana C Liberman; Maria Antunica-Noguerol; Viviane Ferraz-de-Paula; Joao Palermo-Neto; Carla N Castro; Jimena Druker; Florian Holsboer; Marcelo J Perone; Sarah Gerlo; Karolien De Bosscher; Guy Haegeman; Eduardo Arzt
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

View more
  9 in total

Review 1.  Glucocorticoid receptors: finding the middle ground.

Authors:  Sofie J Desmet; Karolien De Bosscher
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

Review 2.  Stress, alcohol and infection during early development: A brief review of common outcomes and mechanisms.

Authors:  P N Surkin; H Brenhouse; T Deak; A C Liberman; M Lasaga
Journal:  J Neuroendocrinol       Date:  2018-08-07       Impact factor: 3.627

3.  Tricyclic antidepressants target FKBP51 SUMOylation to restore glucocorticoid receptor activity.

Authors:  Maia L Budziñski; Clara Sokn; Romina Gobbini; Belén Ugo; María Antunica-Noguerol; Sergio Senin; Thomas Bajaj; Nils C Gassen; Theo Rein; Mathias V Schmidt; Elisabeth B Binder; Eduardo Arzt; Ana C Liberman
Journal:  Mol Psychiatry       Date:  2022-03-08       Impact factor: 13.437

Review 4.  The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease.

Authors:  Gabriel R Fries; Nils C Gassen; Theo Rein
Journal:  Int J Mol Sci       Date:  2017-12-05       Impact factor: 5.923

5.  A comprehensive platform for the analysis of ubiquitin-like protein modifications using in vivo biotinylation.

Authors:  Lucia Pirone; Wendy Xolalpa; Jón Otti Sigurðsson; Juanma Ramirez; Coralia Pérez; Monika González; Ainara Ruiz de Sabando; Félix Elortza; Manuel S Rodriguez; Ugo Mayor; Jesper V Olsen; Rosa Barrio; James D Sutherland
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

6.  Post-translational modifications and stress adaptation: the paradigm of FKBP51.

Authors:  Theo Rein
Journal:  Biochem Soc Trans       Date:  2020-04-29       Impact factor: 5.407

Review 7.  The Many Faces of FKBP51.

Authors:  Andreas Hähle; Stephanie Merz; Christian Meyners; Felix Hausch
Journal:  Biomolecules       Date:  2019-01-21

Review 8.  Regulatory and Mechanistic Actions of Glucocorticoids on T and Inflammatory Cells.

Authors:  Ana C Liberman; Maia L Budziñski; Clara Sokn; Romina Paula Gobbini; Anja Steininger; Eduardo Arzt
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-16       Impact factor: 5.555

9.  Relationship Between Homodimeric Glucocorticoid Receptor and Transcriptional Regulation Assessed via an In Vitro Fluorescence Correlation Spectroscopy-Microwell System.

Authors:  Sho Oasa; Shintaro Mikuni; Johtaro Yamamoto; Tsumugi Kurosaki; Daisuke Yamashita; Masataka Kinjo
Journal:  Sci Rep       Date:  2018-05-10       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.